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MYELOMA PROTEINS AND ANTIBODIES* 
HENRY G. KUNKEL 
The Rockefeller lnstitttte, New York, New York 
I. INTRODUCTION 
A GAMMAGLOBULINEMIA represents one disease which has very
£1... aptly been termed "an experiment of nature" because of the 
large body of widely useful information gained through clinical 
investigation of patients with this condition. Another such disease, 
at the opposite extreme with tremendous overproduction of r
globulin, is multiple myeloma, which shows promise of proving 
of even greater utility and represents another area where clinical 
investigation has much to offer for the elucidation of a variety of 
basic problems in immunology. 
There is no more intriguing question in biology today than that 
of antibody specificity. How is it acquired from the antigen and 
what are the permutations and combinations of the y-globulin 
molecule which endows it with an individual specificity? It is a 
problem, however, that has proved uniquely difficult to attack, 
primarily because of the difficulty in isolating in workable quanti­
ties antibodies to single antigenic determinants. In fact, valid 
question remains whether this has ever been accomplished even 
in small amounts. As an alternative, the readily available myeloma 
proteins have been and will certainly continue to be utilized. 
The possibility exists that they themselves represent individual 
antibodies, the products of the single plasma cells that gave rise 
to the clone of myeloma cells. Some support for this concept has 
arisen recently from the discovery of antibody-like activity for a 
number of the Waldenstrom type macroglobulins (Kritzman 
et al., 1961 ) . Irrespective of the final settlement regarding this 
question, one conclusion has become apparent to all who have 
worked with these and the related Bence-Jones proteins and 
* Lecture delivered March 16, 1964.
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macroglobulins, and that is, that every piece of information gained 
from their study, no matter how seemingly irrelevant, is directly 
applicable to the problem of normal ,,-globulin and individual 
antibodies. This point represents the main theme of this paper. 
Bence Jones proteins were .first described in 1845, more than 
a hundred years ago. The story of how Sir James Watson sent 
a bottle of urine to Dr. Henry Bence Jones for special study has 
been recounted many times in traditional British fashion. The 
equally and perhaps more significant discovery of the myeloma 
protein in the serum and its distinction from the urinary Bence 
Jones proteins by Geschickter and Copeland ( 1928) at Johns 
Hopkins Hospital, has scarcely been noticed. Their study initiated 
an interest in the relationship of the serum and urinary protein 
which is certainly a lively one at the present day. Mention also 
should be made of the early work of Dr. Stanhope Bayne-Jones 
on Bence Jones proteins ( 1922); the correspondence in names can 
scarcely have been fortuitious. He was one of the first to carry 
out immunological studies. In fact in reading through this work 
recently, it was rather shocking to see how similar certain of his 
conclusions on immunological subgroups were to some presum­
ably original ones in a recent paper of ours. Progress in the 
myeloma field shiften from Baltimore to New York with the 
now classical studies of Gutman and associates ( 1941 ) on the 
physical characteristics of the serum and urinary proteins. In the 
more clinical area, Dr. Snapper assembled a vast amount of useful 
information and stimulated interest in a variety of therapeutic 
possibilities (Snapper et al., 1953). 
Our own interest in this field approximately fifteen years ago 
with studies employing antisera to the newly available Fr II 
,,-globulin (Kunkel et al., 1951). This work indicated that the 
myeloma proteins were closely related antigenically to normal 
,,-globulin. The earlier investigators were more impressed with 
the antigenic uniqueness of the myeloma and Bence Jones pro­
teins, a topic which is of considerable current interest and to 
which I will return later. Reactions with normal serum and 
,,-globulin had been dismissed as due to contaminants. The con­
cept of paraproteins or abnormal proteins was firmly entrenched 
and even today continues to have a few adherents. 
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Figure 1, taken from these early studies, shows precipitin 
curves obtained from the reaction of an antiserum to Fr II 
y-globulin and dilutions of two myeloma sera and one normal
serum. The point of equivalence is shifted markedly to the left
for the myeloma sera. The only explanation for these findings
was that the myeloma proteins in these sera reacted with the
anti-Fr II antibodies. In fact, the concentration of the myeloma
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FIG. 1. Precipitin curves of serial dilutions of two myeloma sera and one 
normal serum with antiserum to Fr II ')'-globulin indicating the reaction of 
antibodies to normal ')'-globulin with the myeloma proteins. From Kunkel 
et al. (1951). 
protein could be grossly quantitated from such curves. The lower 
equivalence peaks for the myeloma sera indicated that not all 
the antibodies to Fr II were reacting with these proteins. If one 
makes a mixture of myeloma proteins, making sure that group I 
and group II types are in the ratio found in normal y-globulin, 
the resulting precipitin curve is very analogous to that of Fr II. 
This is also true of other properties that have been examined. 
Extensive studies of this type (Slater et al.} 1955; Mannik and 
Kunkel, 1962; Mannik and Kunkel, 1963a Harboe et al.} 1962a) 
along with those of Deutsch and associates ( 1956), have led to 
the concept that y-globulin represents a composite mixture of 
proteins which individually closely resemble the myeloma pro-
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teins. This is illustrated semidiagrammatically for orientation pur­
poses in Fig. 2. The broad distribution of y-globulin in the elec­
trophoretic spectrum of serum is illustrated along with hypothet­
ical myeloma proteins distributed over the same mobility range 
as for the normal y-globulin. Figure 2 illustrates only one dimen­
sion of difference among these proteins, that is, electrophoretic 
mobility. It has become evident that many others exist and that 
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Frc. 2. Schematic drawing illustrating the broad distribution of -y-globulin 
m the zone electrophoresis pattern and the distribution of individual rnyeloma 
proteins over a similar area. 
normal y-globulin must be considered a myriad of different 
proteins each of which may have a myeloma counterpart. 
II .. /32A MYELOMA PROTEINS AND ANTIBODIES 
Even in the earliest antigenic studies it became apparent that 
approximately one-fourth of the myeloma proteins behaved very 
differently and were very distantly related to Fr II. There was 
another component in normal serum which migrated between 
they and f3 area to which these myelomas were very similar. This 
finding (Slater et al., 1955) led, following the development of 
immunoelectrophoretic techniques, to the delineation of a separate 
class of immunoglobulins, the /32A or '}'rA class ( Heremans, 1960; 
Tomasi and Zigelbaum, 1963). 
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In normal serum the /32A class of immunoglobulins represents 
a minor component, of approximately one-fourth the concentra­
tion of the major 7 S type of y-globulin. However, in other body 
fluids particularly external secretions, it frequently represents the 
dominant type of immunoglobulin (Tomasi and Zigelbaum, 
1963). Current interest has centered on the assignment of anti­
body activity to this class and an understanding of its biological 
significance. A relatively simple procedure for detecting /32A 
antibodies has been applied to the isoagglutinins (Kunkel and 
Rockey, 1963). Washed specific precipitates between blood group 
A substance and human serum containing anti-A antibodies are 
dissolved in antigen excess and applied to the central wall of 
an agar plate. Specific antisera to the various immunoglobulins 
in the outside wells delineate the antigenic character of the anti­
body. /32A antisera that react only with this class of immuno­
globulin give distinct lines with the dissolved antibody from most 
sera. Quantitative analysis indicates that in most instances less 
than 20% of the antibody was of the /32A type. Recently, several 
anti-B antibodies have been obtained from human sera which 
show the /32A type as the dominant species. Other workers have 
also described /32A antibodies utilizing a variety of methods 
(Fireman et al., 1963; Fahey and Goodman, 1964). 
Another more complex procedure that has proved useful for 
the delineation of the type of antibody in specific sera has been 
density gradient ultracentrifugation or combination of this tech­
nique with chromatography (Rockey and Kunkel, 1962). Figure 
3 illustrates the results for one anti-A serum separated first by 
chromatography and then by density gradient ultracentrifugation 
of the chromatographic fractions. Three types of antibody activity 
are shown which differ both in chromatographic and in sedimen­
tation characteristics. These represent the usual 7 S and 19 S types 
plus an additional type with an intermediate sedimentation rate. 
The latter type are the subject of considerable current interest. 
Most of the /32A antibodies in the isoagglutinin system show this 
property. The subject is confused, however, by the additional 
occurrence of isoagglutinins of intermediate sedimentation rate 
which are not of the /32A class but appear to be polymers of 
ordinary 7 S y-globulin. This type was observed in many anti-A 
sera. 
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FIG. 3. Distribution of anti-A antibody activity following density gradient 
ultracentrifugation of three column fractions of serum. The solid lines represent 
the protein curves and the bars the antibody activity. The upper pattern repre­
sents 7 S antibody, the lower pattern 19 S antibody, ant the middle pattern 
antibody of intermediate sedimentation rate. From Rockey and Kunkel ( 1962). 
The finding of /32A antibodies of intermediate sedimentation 
properties was expected in view of the wide occurrence of /32A 
type myeloma proteins which exist in polymeric forms (Laurell, 
1961). As in the case of the Waldenstri::im macroglobulins these 
appear to represent basic four-chain structures which are sec-
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ondarily linked by readily split disulfide bonds; these polymers 
are very variable in size, however (Mannik and Kunkel, 1964) 
( cf. Fig. 4). The bulk of our knowledge concerning the /32A 
class proteins has arisen from the study of the myeloma proteins, 
and in fact it is highly doubtful that we would even recognize 
today this important class of antibodies if it had not been for the 
striking properties of the myeloma proteins of this type. 
III. CHAIN STRUCTURE OF y-GLOBULIN AND 
THE GENETIC FACTORS 
One of the major recent developments in the y-globulin field 
has been the elucidation of the multiple chain structure of these 
proteins. This began with observations on the dissociation of 
Waldenstrom macroglobulins with sulfhydryl compounds and 
has been extended to include all the immunoglobulins. It is now 
apparent that each of these proteins is made up of two types of 
polypeptide chains that differ markedly from each other. Dr. 
Gerald Edelman, who began this work in our laboratory, has 
been responsible for many of these important developments. 
After reduction with agents such as mercaptoethanol, the chains 
of all the immunoglobulins can be separated by a variety of 
methods. It is perhaps brought out most clearly by starch gel 
electrophoretic separation (Edelman and Poulik, 1961), but the 
chains also can be separated by a variety of other methods 
(Fleischman et al.) 1963). Here again work with myeloma pro­
teins aided considerably, and the sharp banding of the L and H 
chains in gel separations were first evident with these proteins. 
A dramatic finding which arose as a consequence of this work 
is that the Bence Jones proteins correspond to the free L poly­
peptide chains from the same patient ( Edelman and Poulik, 
1961). The recent observation (Franklin et al.) 1963; Osserman 
and Takatsuki, 1963) of patients with a myeloma-like picture 
who produce very large amounts of material resembling free H 
chains in some ways completes the picture. Both the L and H 
chains seem to appear in disease in the uncombined state, but thus 
far never in the same patient. 
A primary question that arose from the elucidation of the 
chain picture or ordinary y-globulin, was what relationship did 
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the H and L chains have to the other immunoglobulins. The 
answer has come from a variety of sources, but perhaps most 
strikingly from investigations of the genetically determined fac­
tors in y-globulin. At least twelve different genetic types of 
human y-globulin can be distinguished in different individuals. 
These have been studied extensively by human geneticists, and 
it is clear that the factors responsible are determined by genes 
present at a number of different loci. Two of these, the Gm and 
Inv loci, are clearly separate. 
TABLE I 
LOCALIZATION OF THE Gm AND Inv FACTORS IN THE FRAGMENTS OF 
-y-GLOBULIN PRODUCED BY PAPAIN 
Phenotype 
Donor Preparation Gm Inv 
L. B. Whole -y-globulin a+b- a-b+
F fragment a+b- a-b-
S fragment a-b- a-b+
R.T. Whole -y-globulin a+b+ a+b+
F fragment a+b+ a-b-
S fragment a-b- a+b+
L. O. Myeloma protein a+b- a-b+
F fragment a+b- a-b-
S fragment a-b- a-b+ 
The Gm and Inv determinants were initially localized to dif­
ferent portions of they-globulin molecule (Harboe et al.) 19626; 
Franklin et al.) 1962) through studies of the S and F fractions 
of y-globulin produced by papain splitting (Table I). This work 
along with studies of the Inv factors in Bence Jones proteins 
indicated that these genetic determinants were on different poly­
peptide chains. 
The direct demonstration of the various genetic factors on the 
isolated chains has been hampered considerably by technical 
problems involved in the isolation of the L and H chains in com­
pletely pure form. In many instances the H chains in particular 
are contaminated by L chains which can be detected antigenically. 
In addition, the H chains are in general very insoluble and are 
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difficult to work with. In fact the best solvent for the H chains 
is a solution of L chains. The strong affinity of these chains for 
each other even when the SH groups are blocked with iodoace­
tamide represents a dramatic phenomenon and makes the forma­
tion of hybrid molecules of various isolated L and H chains com­
paratively easy. At present there are no published data available 
concerning the direct localization of the GM and Inv characters 
to the L and H chains. Our laboratory has had limited results for 
a number of years which confirmed the previous experiments 
TABLE II 
Gm AND Inv PHENOTYPES OF THE WHOLE -y-GLOBULIN AND L AND H 
CHAINS FROM DIFFERENT INDIVIDUALS 
Native protein L chains H chains 
Preparation Gm Inv Gm Inv Gm Inv 
Normal -y-globulin a+b-x+ a- a-b-x- a- a+b-x+ a-
a+b-x+ a- a-b-x- a- a+b-x+ a-
a-b+x- a- a-S-x- a- a-b+x- a-
a-b+x- a+ a-b-x- a+ a-b+x- a-
Myeloma protein a+b- a- a-b-x- a- a+b- a-
a-b- a- a-b-x- a- a-b- a-
a-b- a- a-b-x- a- a-b- a-
a-b- a- a-b-x- a- a-b- a-
a-b- a+ a-b-x- a+ a-b- a-
with other methods. This also has been the case with other 
laboratories. Recently, Dr. Mart Mannik in our group isolated 
the L and H chains from various preparations of normal 
y-globulin and myeloma proteins, utilizing essentially the method
of Fleischman et al., ( 1963). These were used primarily for
hybridization experiments, but some data on the better prepara­
tions were obtained concerning the genetic factors. Table II in- .
dicates certain of the results obtained. Unfortunately the more
widely prevalent Inv ( b) factor could not be measured because the
reagent for this system is no longer available. However, it was
clear that the Gm factors were found only on the H chains, and
the Inv factors only on the L chains.
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The localization of these genetic factors to the other immuno­
globulins was made relatively easy through the use of myeloma 
proteins and Waldenstrom type macroglobulins. Clear-cut re­
sults were obtained which demonstrated that the Gm determinants 
were limited to 7 S y-globulin whereas the Inv determinants 
extended to all classes of immunoglobulins including the Bence 
Jones proteins. Table III summarizes such results from our 
laboratory. 
TABLE III 
Gm AND Inv TYPES OF ISOLATED MYELOMA PROTEINS, MACROGLOBULINS, 
AND URINARY BENCE ]ONES PROTEINS 
Gm type Inv type 
Class of 
protein a+b- a+b+ a-6+ a-6- a+b- a+b+ a-6+ a-6-
7 S -y 15 0 2 30 3 0 17 6 
19 S -y 0 0 0 6 0 0 2 4 
f32A 0 0 0 15 1 0 9 5 
Bence Jones 0 0 0 11 1 0 5 5 
Experiments were also carried out on the 19 S proteins of six 
normal sera of different phenotypes and compared with the 7 S 
y-globulin isolated from the same sera ( Harboe and Osterland,
1963). This was a very laborious task ·and has not as yet been
completed for the /32A proteins (Table IV). Again, Gm activity
was completely absent in the isolated 19 S material, while the Inv
Serum 
1 
2 
3 
4 
5 
6 
TABLE IV 
GENETIC TYPES OF 7 S AND 19 S -y-GLOBULIN 
PURIFIED FROM Six NORMAL SERA 
7 S -y-globulin 19 S -y-globulin 
Gm(a+b+) Inv(a+b+) Gm(a-6-) Inv(a+b+) 
Gm(a+b+) Inv(a+b+) Gm(a-6-) Inv(a+b+) 
Gm(a+b+) Inv(a-6+) Gm(a-6-) Inv(a-6+) 
Gm(a+b+) Inv(a-6+) Gm(a-6-) Inv(a-6+) 
Gm(a+b+) Inv(a-6+) Gm(a-6-) Inv(a-6+) 
Gm(a-6+) Inv(a-6+) Gm(a-6-) Inv(a-6+) 
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type corresponded in each case to that for the 7 S fractions. In 
fact, the presence of Gm activity proved to serve as a useful tool 
in detecting contamination of 19 S fractions by 7 S y-globulin. 
Thus the L chains for each class of immunoglobulins must be 
very closely related and appear to be under similar genetic control. 
The H chains, however, are known to be completely different 
antigenically and in turn appear to be under independent genetic 
control. Recent observations on the H chain subgroups of 7 S 
7S 19S f32A 
s
I s 
I s
I s 
I X(l-4) 
s 
X(6) I 
FIG. 4. Schematic diagram of the tentative chain structure of the three types 
of immunoglobulins. The polymeric form of the 19 S and of some {J2A proteins 
is illustrated. Each type has similar L chains and different H chains. 
y-globulin ( Grey and Kunkel, 1964) indicate that each of
these contain different genetic determinants controlled by genes
at closely linked loci (Kunkel et al., 1964). This work has
led to the concept of a cluster of closely linked and partially
similar structural genes in a "H chain" region of the chromosome.
It seems likely that the loci involved in the H chains of 19 S and
/32A immunoglobulins are also closely linked to the 7 S group .
Figure 4 illustrates a tentative chain structure diagram for the 
three classes of immunoglobulins based on the antigenic and 
genetic studies mentioned above as well as starch gel elec­
trophoresis analyses (Edelman, 1963; Carbonara and Heremans, 
1963). A variety of observations indicate that the 19 S proteins 
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represent polymeric forms of a basic four-chain unit similar to 
7 S y-globulin. There are approximately six basic units in the 
19 S class, linked by single disulfide bonds attached to the H 
chains (Kunkel et al.J 1961). The /32A class is very incompletely 
studied at present but reduction experiments suggest a similar 
situation to that occurring in the 19 S class. However, in this 
group there is considerably greater variability in the degree of 
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From Harboe et al. ( 1962a). 
polymerization ranging from a monomeric form to quite large 
polymers. A great heterogeneity of these forms has been ob­
served in different myeloma proteins of the /32A class. 
Another finding that arose from the studies of the genetic 
characters in isolated myeloma proteins was the selective oc­
currence in these proteins of only one of each pair of apparent 
allelic factors in heterozygous individuals. This is illustrated in 
Fig. 5, showing the method of analysis for the Gm factors in both 
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the myeloma protein and the normal y-globulin of that in­
dividual ( Harboe et al., 1962a). Each tube was brought to the 
same protein concentration ( 1 mg. /ml.) for the assay. No 
myeloma protein typed out as Gm ( a+b+) or Inv ( a+b+), al­
though Gm and Inv factors could be detected in the same mye­
loma. This series has been extended considerably now from work 
in various laboratories, and no exception to this rule has been 
found. This also applies when measurements are made for the 
new Gm ( f) factor which behaves like an allele of Gm (a) . Most 
of the myeloma proteins which were previously Gm negative 
are positive in the Gm ( f) system. 
The interpretation of these data is subject to some problems in 
the light of recent observations on H-chain subgroups demon­
strating that Gm ( b) and Gm (a) may not be the products of 
allelic genes (Kunkel et al., 1964). However, the occurrence 
of Gm ( f) in the same subgroup of 7 S y-globulin as Gm (a) 
raises the possibility that these two factors may be controlled by 
true alleles, and these factors are also never found in the same 
myeloma proteins in heterozygous individuals. 
Studies with isolated antibodies, carried out primarily by Dr. 
James Allen in a collaborative study with Dr. Elvin Kabat, indi­
cate that many of these show a picture very similar to the myeloma 
proteins with selective occurrence of the genetic factors and fre­
quent absence of characters which occur in the individual's 
y-globulin ( Allen et al., 1964). The problem here is compli­
cated by the fact that most of the antibodies studied are directed
against multiple determinants. However, every indication points
to the fact that the behavior of the best preparations approach
closely that of the myeloma proteins.
These variable ratios of genetic factors in presumed hetero­
zygous individuals indicate that antibody-producing cells must 
differ in their synthesis of proteins carrying these factors possibly 
reaching the extreme picture observed for the myeloma proteins. 
Experiments with the rabbit allotypes indicate a similar picture 
with variable ratios of genetic factors in different isolated anti­
bodies (Rieder and Oudin, 1963). However, recent fluorescent 
antibody studies for one allelic system have not shown differential 
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labeling for one or the other factor in heterozygous animals ( Col­
berg and Dray, 1964). This finding does not explain the variable 
ratios in different rabbit antibodies and does not fit with the 
findings for humans. It will be most important to resolve these 
apparent discrepancies. 
IV. SUBGROUPS OF 7 S y-GLOBULIN INVOLVING 
L CHAINS AND H CHAINS 
In addition to the genetic differences in 7 S y-globulin multiple 
subclasses of 7 S y-globulin have been found that appear to be 
present in all individuals. Most antisera to normal y-globulin give 
a single band with Fr II y-globulin and normal serum by im­
munoelectrophoretic analysis. This led many early workers, not 
influenced by the antigenic heterogeneity of the myeloma pro­
teins, to consider y-globulin antigenically homogeneous. How­
ever, many antisera clearly suggested that this was not the case. 
Particularly striking were antisera to /32A myeloma proteins and 
Waldenstrom macroglobulins, which frequently showed double 
lines when allowed to react with Fr II (Edelman et al., 1960). 
This double-line phenomenon suggested two major classes of 
y-globulin. However, despite considerable effort it proved ex­
tremely difficult to demonstrate this satisfactorily. The elucida­
tion of the phenomenon came through an appreciation of a rela­
tionship to the two classes of Bence Jones proteins that had long
been known. Antisera to these Bence Jones proteins divided all
classes of immunoglobulins into two groups. It had been known
ever since the work of Bayne-Jones ( cf. Bayne-Jones and Wilson,
1922) that at least two major antigenic groups of Bence Jones
proteins existed. These were clearly brought out through the
studies of Korngold and Lipari ( 1956). Antisera to each type
were completely specific with no evidence of a cross reaction be­
tween the two. This clear difference has also become apparent
through recent peptide analyses (Putnam, 1962). There are no
recognizable tryptic peptides that are shared. Despite these strik­
ing differences, both types show the classical solubility properties
of Bence Jones proteins.
Specific antisera to each type of Bence Jones protein divided 
7 S myeloma proteins, /32A myeloma proteins, and W aldenstrom 
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macroglobulins into two distinct groups termed groups I and II 
(Mannik and Kunkel, 1962; Fahey, 1963) (Fig. 6). Fr II 
y-globulin as well as the y-globulin from single normal in­
dividuals also consisted of a mixture of the two types which
could be quantitated (Mannik and Kunkel, 1963a). Figure 7
illustrates the method employed in our laboratory utilizing l131-
labeled y-globulin. Approximately 60% of the y-globulin pre­
cipitated with antisera to group I Bence Jones proteins, and ap-
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?Sy-Globulins 
H ---LI 7Sr----
H1sy---­
---L I 
19Sy-Globulins 
---LI H 19Sy Hr,-&-· .. ,., .  , .. ··I 
,B2A-Globul ins 
rL -Globulins 
H 19Sy •A .1., ..... .. ·&-··J 
---L i 
H,82A ---Lr 
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---LI
---Li 
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H 7S y ---- - _- LII 
H1sr ---­
---LII 
H19Sy I· 
---LII ., ·� •..• _.,. ···-4 
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�LII 
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FIG. 6. Diagram of the different immunoglobulins illustrating the distribution 
of group I and group II L chains among all types. The ')'L refers to the free L 
chains found in the urine (Mannik and Kunkel, in press). 
proximately 30% with the antisera to group II proteins. The com­
bined antisera produced exact additive effects indicating that the 
individual molecules were not both group I and group II. As 
expected, isolated L chains from y-globulin contained the two 
types of antigenic determinants, and these could be similarly 
divided by means of the Bence Jones antisera. In fact isolated 
L chains reacted considerably better with these antisera than did 
the whole y-globulin molecules. This was due to the fact that 
many of the antibodies were directed against L-chain determinants 
that were blocked by H chains in the combined form of y-globulin. 
The simple addition of H chains to L chains in recombination 
experiments demonstrated this phenomenon (Kunkel, Solomon, 
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and Grey unpublished observations) . In the course of this work it 
was apparent that group II antisera were more heterogeneous than 
the group I types and contained strong specificities other than 
those to the group antigens. 
It was of considerable interest than the 60: 30 ratio of group I 
to group II molecules in y-globulin was almost identical to the 
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FIG. 7. Precipitin curves with 1131-labeled Fr II and group I and group II 
antisera (left), indicating the percentage of protein in each group. x--x 
indicates protein, and x---x indicates percentage of radioactivity precipitated 
by a group I antiserum; o--o and o---o indicate the same for a group II 
antiserum. 
On the right, the curves indicate the protein and radioactivity precipitated 
by a mixture of group I and group II antisera ( o--o, o---o) and by an 
antiserum to whole Fr II (x--x, x-x). From Mannik and Kunkel 
(1963a). 
incidence of group I versus group II myeloma proteins ( Mannik 
and Kunkel, 196 3a) . No evidence was obtained for a significant 
variation in this ratio in the y-globulin of individuals of various 
ethnic and geographical groups. However, the study of isolated· 
antibodies indicated considerable deviations in this ratio ( Man­
nik and Kunkel, 19636). Figure 8 illustrates the marked dif-
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ference between two antiteichoic acid antibodies. Several anti-A 
antibodies stood out in consisting of primarily group II molecules. 
The cold agglutinins of seven cases of cold agglutinin disease 
were entirely group I. It appeared as if antibodies to single de­
terminants might very well consist of purely one group or the 
other analogous to the myeloma proteins, Waldenstrom macro­
globulins and Bence Jones proteins. 
FIG. 8. Two agar slides showing the reaction of serial dilutions of two iso­
lated antiteichoic acid antibodies with group I and group II antisera. Upper 
trough in each slide contains a group II antiserum, and the lower trough a 
group I antiserum. The upper antibody shows greatest reactivity with the 
group I antiserum while the lower shows a greater reactivity with the group II 
antiserum. From Mannik and Kunkel ( 19636). 
As in the case of the L chains, antigenic analyses have demon­
strated a number of subgroups which reflect differences in the H 
chains of 7 S y-globulin. These H-chain differences are not as 
complete as those for the group I and II L chains and common 
antigens have always been detected. Four H-chain subgroups 
have been delineated through the use of specific antisera to in­
dividual myeloma proteins ( Grey and Kunkel, 1964). Follow­
ing absorption with myeloma proteins of heterologous subgroups, 
specific reactions for the group concerned can be obtained. Tern-
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porary names have been assigned these subgroups according to 
the initial myeloma protein employed as antigen in the produc­
tion of the specific antisera. Quantitative precipitin studies with 
such antisera have permitted an estimate of the approximate 
quantity of the various subgroups in pooled as well as individual 
specimens of isolated y-globulin. The major We group consists 
of approximately 60% of the total y-globulin in Fr II, and the Vi 
group, approximately 8o/o. The Ne group and Ge group have 
not been as closely quantitated, but it is clear that the Ne group 
ranges between 10 and 20% and the Ge group represents a 
minor fraction. These figures agree again with the approximate 
incidence of myeloma proteins of each of the subgroups. A num­
ber of studies with isolated y-globulin of representative sera 
from different ethnic and geographic groups have not shown 
any consistent difference in the relative quantity of these sub­
groups. 
The most interesting finding arising from the study of these 
subgroups is that each appears to contain its own set of genetic 
factors (Kunkel et al.J 1964). In fact the two major factors 
in the Gm system proved to be on different group proteins. 
Gm (a) was found only in We group myeloma proteins, and 
Gm(b) only in Vi group proteins. The other two groups con­
tained no currently recognizable Gm factors. 
V. INDIVIDUAL ANTIGENIC SPECIFICITY OF MYELOMA 
PROTEINS AND ISOLATED ANTIBODIES 
There is one further subject which is particularly relevant with 
regard to the variation in the chains of y-globulin, and this con­
cerns the individual antigenic specificity of myeloma proteins. It 
has long been known that antisera to single proteins of this type 
react to a greater degree with the homologous antigen than with 
other myeloma proteins or normal y-globulin ( Slater et al. J 
1955). This has led many to the conclusion that these are ab­
normal proteins. The individual specificity is brought out 
strikingly with many antisera by spur formation of the homol­
ogous myeloma protein over other myeloma proteins and prepara­
tions of y-globulin. Great variation is observed from one anti­
serum to another in the extent of this specificity, although it is 
MYELOMA PROTEINS AND ANTIBODIES 237 
found in the great majority of antisera. Absorption experiments 
with pooled y-globulin also bring out this great variation. Some 
antisera lose this specificity entirely after absorption with large 
amounts of ,,-globulin, others lose it partially, and a few are very 
little affected. Figure 9 shows an example of the effect of various 
concentrations of pooled ,,-globulin on the specificity of myeloma 
Vi with anti-Vi antiserum. Absorption with 2 mg. of ,,-globulin 
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FrG. 9. Precipitin curves of isolated myeloma Vi with anti-Vi antiserum 
absorbed with increasing amounts of pooled '}'-globulin. The amount of protein 
precipitated at equivalence decreases but some individual specificity remains 
even after the addition of SO mg. of Fr II per milliliter of antiserum. 
removes the reactivity with ,,-globulin and myeloma proteins of 
heterologous groups. Absorption with 10 mg. removes the 
specificity for Vi group proteins and leaves only the individual 
specificity. Absorption with 50 mg. reduces this partially and 
100 mg. slightly further, but some individual specificity remains. 
With many antisera, continued absorption with large amounts 
of ,,-globulin gradually lowered the precipitin curve for the in­
dividual specific reaction. It appeared as if there frequently 
existed determinants in small amounts in pooled ,,-globulin that 
resembled those of the antigen. 
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The localization of the specificity on the chains of y-globulin 
has proved quite difficult. In certain instances the specificity can 
be demonstrated on the L chains (Mannik and Kunkel, 1963c) 
and in others on the H chains. However, in most instances it 
requires combination of the H and L chains to be evident ( Grey 
et al., to be published). The quaternary structure of the molecule 
appears to be most important m this type of antigenic indi­
viduality. 
A large number of studies of isolated antibodies over the 
past twenty years have led to the conclusion that these are not 
antigenically distinct and give rise to antibodies closely analogous 
to those obtained with normal y-globulin. In view of the striking 
findings regarding individual specificity in the myeloma field, this 
problem was reinvestigated with some new isolated antibodies 
against limited antigenic determinants. Animals were immunized 
with isolated anti-A, anti-B, anti-dextran, anti-levan, and anti­
teichoic acid antibodies. Individual specificity was found in a 
number of instances (Kunkel et al., 1963). Figure 10 illustrates 
one example of this specificity for an anti-A antibody. Antisera 
FIG. 10. Agar plate analysis showing the specific reaction of isolated antibody 
Th with anti-Th antiserum (A). Peripheral wells 2-5 contain ,y-globulin 
preparations of different types, and wells 6-12 contain heterologous isolated 
anti-A antibodies. The antiserum (A) was absorbed with 5 mg. Fr JI per milli­
liter of serum. From Kunkel et al. ( 1963). 
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to two different anti-A antibodies showed complete individual 
specificity and both of these failed to react in a similar fashion 
with any of fifteen other isolated anti-A antibodies. This has also 
proved true even more strikingly with the 19 S cold agglutinins. 
The accumulated evidence indicates that this individual specificity 
is unrelated to the antibody site of these antibodies. 
Thus in this final distinct characteristic isolated antibodies be­
haved in all respects like myeloma proteins. There have been no 
exceptions to this rule although it is of course important to con­
tinue to be alert to this possibility. 
VI. DISCUSSION 
Any discussion of antibodies would have to be considered in­
complete if it did not offer some hypothesis on that question that 
has certainly had its share of hypotheses, the mechanism of anti­
body formation. Perhaps two of the points described have special 
relevance and offer some clues to at least the latter stages of anti­
body synthesis. The first is the large number of groups, sub­
groups, and sub-subgroups that exist for both the H and L chains 
with evidence of distinct chemical differences. The second con­
cerns the commitment of the individual cell or clone of cells to a 
selective type of polypeptide chain. Evidence is available that 
group I and group II L chains can be produced by the same cell. 
Yet, after antibody synthesis begins, there is selective synthesis of 
these types. We know that the cell has the capacity to produce 
the allelic genetic factors in heterozygous individuals, yet the 
committed cell produces very variable ratios of these factors. It 
would seem as if the two chains most complementary to the anti­
gen are selected for increased synthesis, probably by a de-repres­
sion mechanism, from a huge number that the cell has the capacity 
to make, or already produces in small amount, with continued 
repression of the synthesis of the remainder. The two selected 
chains then come together producing the final four-chain struc­
ture with even greater complementarity. 
Such a concept places a dominant role on the individual cell 
in determining the type of protein chosen for synthesis and differs 
from various clonal selection theories. The multiplicity of genetic 
factors. already discovered along with the clear indication for 
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many more as yet undetected, offers a· tremendous source of 
heterogeneity for both the L and H chains. This potential is 
possessed by each cell and in some unknown fashion might be 
utilized by the cell in the production of proteins of different 
structures and specificities. In a process of this kind it would seem 
unlikely that any two individuals would ever produce exactly 
the same type of antibody even to the same limited antigenic de­
terminant. The results obtained with the individual antigenic 
specificity of various antibodies suggest that this indeed is the 
case. 
The time is near for a large-scale chemical attack on this prob­
lem, and the myeloma and Bence Jones proteins will undoubtedly 
serve as the subject materials. The antigenic approach described 
above, which has served to delineate subgroups involving both 
the L and H chains and multiple genetic factors, has thus aided in 
providing an overall picture of this unique and complex system 
and has furnished a more rational basis on which the chemistry 
can eventually evolve. 
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